EXPO

Business Context and Reporting Period

Company: Exponent, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: October 1, 2010 (Third Quarter of Fiscal 2010)
Business Overview: Exponent is an engineering and scientific consulting firm providing solutions to complex problems involving litigation, product development, regulatory compliance, and environmental health. The company operates on a 52-53 week fiscal year.

Key Financial Metrics

Margins (Three Months Ended Oct 1, 2010):
- Operating Margin: 17.4% ($11,570 / $66,306)
- Net Profit Margin: 11.8% ($7,820 / $66,306)
- EBITDA Margin (vs. Revenues before reimbursements): 25.0%

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased 20.0% in the third quarter and 5.8% for the nine-month period compared to the prior year. Revenues before reimbursements grew 12.0% (Q3) and 5.8% (9mo).
• Profitability: Net income increased 34.0% in the third quarter and 21.1% for the nine-month period. Operating income rose 38.0% (Q3) and 27.7% (9mo).
• Product Sales: Product sales in the defense technology development practice surged 232% in the third quarter to $7.3 million, driven by surveillance system sales to the U.S. Army.
• Reimbursable Expenses: Increased 105.3% in the third quarter due to higher project-related costs in the technology development practice.
• Utilization: Technical utilization improved to 71% in the third quarter (up from 67% in the prior year) due to effective headcount management.
• Cash Flow: Net cash provided by operating activities for the nine months ended Oct 1, 2010, was $23.1 million, a significant increase from $6.7 million in the prior year period.

Guidance, Outlook, and Risks

Management Commentary & Outlook:
Management expects to focus on selectively hiring new talent to maintain or improve utilization, managing operating expenses, and generating cash from operations. The company plans to continue share repurchases to enhance shareholder value. No specific quantitative financial guidance for the full year was provided in this text.

Risks and Contingencies:
- Legal Proceedings: The company is defending against a writ from a former client regarding testimony in an adverse verdict (currently under appeal) and a class-action lawsuit filed in March 2010 alleging California Labor Code violations. Management believes neither will have a material adverse effect. - Market Risks: Exposure to interest rate risk (managed via short-term debt instruments) and minimal foreign currency exchange risk. No derivatives are used. - Operational Risks: Lack of sizable backlog makes future revenues less predictable. The business is sensitive to economic downturns, tort reform, and the ability to attract and retain key technical personnel. - Goodwill: The company holds $8.6 million in goodwill, which is subject to impairment testing. A sustained decline in stock price could trigger impairment charges.

Key Facts for Investor Verification

• Revenue Composition: Verify the sustainability of the 232% increase in product sales to the U.S. Army, which drove a significant portion of Q3 growth.
• Reimbursement Impact: Note that a large portion of revenue growth (105% increase in reimbursable expenses) is pass-through costs; analyze "Revenues before reimbursements" for core service growth.
• Stock Repurchases: The company repurchased 243,802 shares for $6.9 million in the first nine months of 2010, with $15.0 million remaining under authorization.
• Deferred Compensation Plan: Changes in the fair value of assets in the deferred compensation plan ($1.2 million increase in Q3) impacted both compensation expense and other income, affecting net income volatility.
• Customer Concentration: While no single customer exceeded 10% of revenue, 12% of Q3 revenue came from federal government agencies.